DBV Technologies and Stallergenes, S.A. (GENP.PA) Enter Into Partnership for the Development of Innovative Treatment of Respiratory Allergies
5/17/2013 10:25:44 AM
More...
|
DBV Technologies and Mount Sinai Hospital Enter Into a Research Collaboration Agreement
5/7/2013 10:23:52 AM
More...
|
DBV Technologies Publishes Its 2012 Registration Document and Its 2012 Annual Financial Report
4/25/2013 12:21:20 PM
More...
|
DBV Technologies, Sanofi (France) (SAN.PA) Sign Manufacturing Agreement
3/5/2013 7:37:13 AM
More...
|
DBV Technologies Reports Full Year 2012 Financial Results and Provides R&D Update
3/4/2013 11:37:54 AM
More...
|
DBV Technologies Reports Full Year 2012 Topline and Provides an Update on R&D Activities
1/31/2013 12:30:12 PM
More...
|
DBV Technologies and INRA Receive Funding to Develop Pediatric Bronchiolitis ("RSV") Vaccine: RSV-NanoViaSkin
1/15/2013 9:37:31 AM
More...
|
DBV Technologies' 2013 Financial Calendar
12/18/2012 9:05:29 AM
More...
|
DBV Technologies and Centre d'Immunologie de Marseille-Luminy (CIML) Enter in a Collaboration Agreement
10/16/2012 10:17:50 AM
More...
|
DBV Technologies Initiates VIPES Phase IIb Clinical Study, the First Global Trial Ever in Desensitization of Peanut-Allergic Children and Adults
8/2/2012 10:43:28 AM
More...
|
|